Advertisement
Advertisement

TNYA

TNYA logo

Tenaya Therapeutics, Inc. Common Stock

0.73
USD
Sponsored
0.00
+0.14%
Aug 07, 15:59 UTC -4
Closed
exchange

Pre-Market

0.74

+0.02
+2.09%

Tenaya Therapeutics, Inc. Common Stock Profile

About

Tenaya Therapeutics Inc. is a biotechnology company. It discovers, develop and deliver curative therapies which address the underlying causes of heart disease. The company's product platform consist Gene Therapy, Cellular Regeneration and Precision Medicine. Tenaya Therapeutics Inc. is based in SOUTH SAN FRANCISCO, Calif.

Info & Links

CEO

Faraz Ali

Headquarters

171 OYSTER POINT BOULEVARD, SUITE 500
SOUTH SAN FRANCISCO, CA 94080, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.tenayatherapeutics.com

Auditor

Deloitte & Touche LLP

Share holders

38

Employees

70

Tenaya Therapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

166.38M

Enterprise Value

88.29M

Enterprise Value/EBITDA(ttm)

-0.90

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

1.49

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

50.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

-3118.65%

Return on Equity(ttm)

-76.77%

Return on Invested Capital(ttm)

-121.50%

Return on Assets(ttm)

-61.96%

Income Statement

Revenue(ttm)

1.34M

Revenue Per Share(ttm)

0.01

Gross Profit(ttm)

1.34M

EBITDA(ttm)3

-98.60M

Net Income Available to Common(ttm)

-103.12M

Diluted EPS(ttm)

-0.53

Share Statistics

Beta (5Y Monthly)

2.83

52-Week Change

8.66%

S&P 500 52-Week Change

21.72%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

224.23M

Dividend Yield

0.00%

Float4

211.51M

% Held by Insiders

2.53%

% Held by Institutions

90.54%

Balance Sheet

Total Cash(mrq)

78.08M

Total Cash Per Share(mrq)

0.35

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

4.52%

Quick Ratio(mrq)

5.75%

Book Value Per Share(mrq)

0.31

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.10

Free Cash Flow(ytd)

-22.96M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement